metastatic/adv melanoma (mML) | |
mML - L2 - all population | |
ipilimumab plus gp100 | MDX010 Ipi plus gp100 vs gp100 MDX010 Ipi plus gp100 vs Ipi ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -